- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
Guidance USE OF PLASMA DONATIONS TO TREAT COVID-19: RECOMMENDATIONS FROM SABTO Recommendations from the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) on the use of
convalescent plasma to treat COVID-19. Get emails about this page THIS PUBLICATION WAS WITHDRAWN ON 1 APRIL 2022 This page has been withdrawn because it’s no longer current. Read more about
living safely with coronavirus (COVID-19). DOCUMENTS [WITHDRAWN] PROPOSAL TO ALLOW RECIPIENTS OF CONVALESCENT PLASMA FOR TREATMENT OF INFECTION WITH SARS-COV-2 TO DONATE PLASMA FOR TREATMENT
OF SARS-COV-2 INFECTED INDIVIDUALS HTML [WITHDRAWN] SABTO RECOMMENDATIONS: PATHOGEN REDUCTION AND BACTERIAL SCREENING ON PLASMA DONATED FOR TREATMENT OF SARS-COV-2 INFECTION HTML DETAILS On
28 April 2020, the Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) held an emergency meeting to discuss temporarily allowing people who have received convalescent
plasma (plasma from people who have had coronavirus) for treatment for COVID-19 to donate plasma themselves. These documents set out the initial proposal and the recommendations from SaBTO.
UPDATES TO THIS PAGE Published 5 June 2020 SIGN UP FOR EMAILS OR PRINT THIS PAGE Get emails about this page Print this page
